TrialJAMA oncology2018
Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial.
Erica H Bell et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
103 papers cite itlatest 60 shown
this paperpooled ittrialcites it